Lovenox (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Lovenox drug offered from sanofi-aventis U.S. LLC. This Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | enoxaparin sodium |
SUBSTANCE NAME: | ENOXAPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-03-12 |
END MARKETING DATE: | 0000-00-00 |
Lovenox HUMAN PRESCRIPTION DRUG Details:
Item Description | Lovenox from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/.4mL) |
START MARKETING DATE: | 2008-03-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0075-0620_2cb4222b-718d-4e8f-96ce-fc65b9a2738f |
PRODUCT NDC: | 0075-0620 |
APPLICATION NUMBER: | NDA020164 |
Other ENOXAPARIN SODIUM Pharmaceutical Manufacturers / Labelers: